Capsaicin Patch May Improve Painful Diabetic Peripheral Neuropathy Symptoms
by Cynthia M. Johnson, MA
Diabetic peripheral neuropathy (DPN) is a type of nerve damage associated with diabetes that affects the feet and legs. It results in pain, numbness, and tingling in the extremities. Current pharmaceutical treatment options include antidepressants, anticonvulsants, or opioid medications, which can result in side effects, interactions, and the risk of addiction, abuse, and withdrawal.
Researchers wanted to evaluate the efficacy and safety of capsaicin in DPN. Capsaicin is a chili pepper extract that produces a burning sensation when applied to the skin. It affects the nerves and reduces the activity of pain receptors. The study, published in the Journal of Pain, found that capsaicin treatment provides modest improvements in pain and sleep quality.
About the study
The double-blindrandomized controlled trial included 369 participants with an average age of 63 years old. The participants had painful DPN for at least one year and were also receiving additional treatment, such as medications. The capsaicin was introduced as an additive therapy. Participants were randomized to one 30-minute treatment with either a capsaicin 8% patch or a placebo patch to painful areas of the feet. Study results were measured at 2, 4, 8, and 12 weeks using 0-10 rating scales for both pain and sleep interference.
The reduction in the mean daily pain score was:
The improvement in mean daily sleep interference scores was:
How Does this Affect You?
A randomized trial is considered the most reliable form of research, but how the research is done will affect its reliability. In this study, many participants in the capsaicin group would have known they received some form of treatment given the reaction at the patch site, which was 33.9% in the capsaicin group compared to 8.2% in the placebo group. The most common reaction was burning sensation and pain at the application site. In addition, there may not be a meaningful reduction in pain for all that initial burning. Scales were used to determine average improvement; however, it is questionable whether participants would have noticed the 7%-9% difference between treatment and placebo groups, especially since they were already receiving other treatments to reduce pain. More studies will need to be done to compare capsaicin patches to traditional treatments to determine efficacy.
Other studies have also determined that capsaicin might reduce neuropathic pain. However, it may not be a practical treatment as many patients may not be able to tolerate its burning side effects. A low-dose cream is currently available to treat DPN pain. Talk to your doctor about whether it is right for you and whether the benefits outweigh the side effects.
American Diabetes Association
Family Doctor—American Academy of Family Physicians
Diabetic peripheral neuropathy. EBSCO DynaMed Plus website. Available at: http://www.dynamed.... Updated May 18, 2017. Accessed May 23, 2017.
Simpson DM, Robinson-Papp J, et al. Capsaicin 8% in painful diabetic neuropathy: a randomized, double-blind, placebo-contgrolled study. J Pain. 2017 Jan;18(1):42-53. Available at:
...(Click grey area to select URL)
Accessed May 24, 2017.
Last reviewed May 2017 by Michael Woods, MD, FAAP
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at email@example.com. Our Health Library Support team will respond to your email request within 2 business days.